Skip to main content
S

Spermosens

Spermosens develops the JUNO-Checked® diagnostic device, which utilizes automated sperm analysis to assess fertilization capacity by measuring sperm binding to egg cell proteins. This technology addresses the challenge of unexplained male-factor infertility, enabling clinicians to select the most appropriate IVF treatment method and potentially reducing the number of cycles required for successful fertilization.

Lund, SwedenFounded 201881K+ followers
Updated 4 months ago

Funding

$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current methods for assessing sperm quality primarily focus on physical characteristics and often fail to identify the underlying causes of male-factor infertility in approximately 40% of cases. This lack of diagnostic precision can lead to multiple unsuccessful IVF cycles, increasing the emotional and financial burden on couples.

Solution

Spermosens is developing the JUNO-Checked® diagnostic device, an automated system that assesses the fertilization capacity of sperm by measuring their ability to bind to egg cell proteins. This innovative approach enables clinicians to identify previously undetectable causes of male infertility and select the most appropriate IVF treatment method, either standard IVF or ICSI, from the outset. By predicting sperm's fertilization potential, JUNO-Checked® aims to reduce the number of IVF cycles needed to achieve pregnancy, leading to quicker and more cost-effective outcomes for patients. The system is designed to be user-friendly, rapid, and have a small footprint, making it suitable for integration into existing IVF workflows.

Target Audience

The primary target audience includes clinicians and embryologists in IVF clinics who seek to improve the accuracy of male infertility diagnosis and optimize IVF treatment selection.

Features

  • Automated sperm diagnostic device measuring sperm binding to egg cell proteins
  • Patented technology to predict the fertilization capacity of sperms
  • Provides results to assist clinicians in selecting between standard-IVF or ICSI
  • Aims to reduce the number of IVF cycles required for successful fertilization
  • Rapid and small footprint diagnostic system
This profile is AI-generated and may contain inaccuracies.